0

Crispr Technology Market by Application and Geography - Forecast and Analysis 2022-2026

  • Published: May 2022
  • Pages: 127
  • SKU: IRTNTR73494
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

The CRISPR technology market share is projected to rise to USD 2.88 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 19.34%.

This CRISPR technology market research report extensively covers market segmentations by the following:

  • Application - Biological application, agricultural application, industrial application, and others 
  • Geography - North America, Europe, Asia, and Rest of World (ROW)

The CRISPR technology market report covers several market vendors, including Addgene Inc., Agilent Technologies Inc., Applied StemCell Inc., Caribou Biosciences Inc., Cellecta Inc., CRISPR Therapeutics AG, Danaher Corp., Editas Medicine Inc., GeneCopoeia Inc., GenScript Biotech Corp., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, New England Biolabs Inc., Novartis AG, OriGene Technologies Inc., PerkinElmer Inc., Synthego Corp., and Thermo Fisher Scientific Inc. among others. Furthermore, this report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches.

What will the CRISPR Technology Market Size be During the Forecast Period?

Crispr Technology Market Size

Download the Free Report Sample to Unlock the CRISPR Technology Market Size for the Forecast Period and Other Important Statistics

 

CRISPR Technology Market: Key Drivers, Trends, and Challenges

The increasing demand for treatment of genetic diseases is notably driving the CRISPR technology market growth, although factors such as ethical issues associated with CRISPR technology may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the CRISPR technology industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key CRISPR Technology Market Driver

One of the key factors driving the global CRISPR technology industry growth is the increasing demand for the treatment of genetic diseases. The evolving landscape of CRISPR technology could end the after-effects of incurable diseases. CRISPR technology offers an opportunity to treat fatal and incurable genetic diseases. The demand for CRISPR technology is increasing as it is easy, fast, and gives inexpensive access to vectors. CRISPR technology has made gene editing possible and the treatment of sickle cell disease and B-thalassemia, Huntingtons', and Parkinsons' diseases. The effective cure of hereditary blindness and cancer using gene therapy is also in the pipeline. The R&D in CRISPR will allow gene editing at a much more granular level and enable the easy removal of any misbehaving gene, which is expected to decrease the effects of deadly genetic diseases such as cystic fibrosis in the forecast period.

Key CRISPR Technology Market Trend

Advent of CRISPR/ Cas9 is one of the key CRISPR technology market trends that is expected to impact the industry positively in the forecast period. Technological advances such as AI, ML, blockchain, advanced analytics, Big Data, IoT, AR, and virtual reality (VR) are expected to pave the way for the adoption of progressive business solutions. Significant investments in R&D have resulted in several technological advances such as CRISPR/Cas9, which is a fast, accurate, efficient, and cost-effective genome editing tool. CRISPR/Cas9 allows researchers to edit parts of the genome by editing the DNA sequence safely and altering the entire gene function. Several other gene-editing technologies, such as transcription activator-like effector nucleases (TALEN) and zinc-finger nucleases (ZFN), have also been launched in the market. 

Key CRISPR Technology Market Challenge

One of the key challenges to the global CRISPR technology industry growth is the ethical issues associated with CRISPR technology. Gene editing is considered unethical as it is associated with the injection of genes into a body and altering the entire gene structure of an organism. For instance, germline modification using CRISPR technology, which specifically targets the egg and sperm cells, enables the inserted gene to be passed on to future generations. The use of such sophisticated gene therapies may trigger an ethical debate across the world, which is a key challenge for the growth of the global CRISPR market. In the US, federal funds cannot be used for research related to CRISPR technology as it is considered unethical. Such factors may limit the growth of the market in the forecast years.

This clustered regularly interspaced short palindromic repeats technology market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major CRISPR Technology Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Addgene Inc.
  • Agilent Technologies Inc.
  • Applied StemCell Inc.
  • Caribou Biosciences Inc.
  • Cellecta Inc.
  • CRISPR Therapeutics AG
  • Danaher Corp.
  • Editas Medicine Inc.
  • GeneCopoeia Inc.
  • GenScript Biotech Corp.
  • Intellia Therapeutics Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Mirus Bio LLC
  • New England Biolabs Inc.
  • Novartis AG
  • OriGene Technologies Inc.
  • PerkinElmer Inc.
  • Synthego Corp.
  • Thermo Fisher Scientific Inc.

 

This statistical study of the CRISPR technology market encompasses successful business strategies deployed by the key vendors. The CRISPR technology market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.

Product Insights and News

  • Agilent Technologies Inc. - The life sciences and applied markets segment provide application-focused solutions that include instruments and software to identify, quantify, and analyze the physical and biological properties of substances and products.
  • Danaher Corp. - The company offers Alt-R CRISPR-Cas9 System, which is an optimized genome editing solution that outperforms other CRISPR approaches for producing on-target, double-stranded DNA breaks.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The CRISPR technology market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Which are the Key Regions for CRISPR Technology Market?

Crispr Technology Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

44% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for CRISPR technology in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The increasing spending on research, the presence of biotechnology companies and vendors that offer gene-editing services, and the high focus on biomedical research by universities and research institutions will facilitate the CRISPR technology market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The COVID-19 pandemic had a positive impact on the regional CRISPR technology market in 2020. CRISPR technology is being used in studying the coronavirus and diagnosing the disease. For instance, the CRISPR-Cas system was being investigated for rapid and specific diagnosis of COVID-19 in 2020. The CRISPR-Cas-based technology helps in diagnosing the SARS-CoV-2 infections within an hour. Further, in March 2021, the US Food and Drug Administration (FDA) approved the first-in-human clinical trial of a CRISPR gene correction therapy with patients having sickle cell disease to scientists from the University of California San Francisco, University of California, Berkeley, and University of California, Los Angeles. Therefore, the global CRISPR technology market will witness growth during the forecast period.

What are the Revenue-generating Application Segments in the CRISPR Technology Market?

Crispr Technology Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The CRISPR technology market share growth by the biological application segment will be significant during the forecast period. The growth of the segment is attributed to the increasing number of biomedical research studies being conducted in universities and research institutions. This is due to increasing awareness about the need for multidisciplinary and interdisciplinary genetics research studies to treat complex diseases and disorders has given a boost to biomedical research.

This report provides an accurate prediction of the contribution of all the segments to the growth of the CRISPR technology market size and actionable market insights on post COVID-19 impact on each segment.

Parent Market Analysis

Technavio categorizes the global clustered regularly interspaced short palindromic repeats (CRISPR) technology market as a part of the healthcare technology market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the CRISPR technology market during the forecast period.

CRISPR Technology Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the CRISPR technology market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

 

CRISPR Technology Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 19.34%

Market growth 2022-2026

$ 2.88 billion

Market structure

Fragmented

YoY growth (%)

18.25

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 44%

Key consumer countries

US, Canada, UK, Germany, and Japan

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Addgene Inc., Agilent Technologies Inc., Applied StemCell Inc., Caribou Biosciences Inc., Cellecta Inc., CRISPR Therapeutics AG, Danaher Corp., Editas Medicine Inc., GeneCopoeia Inc., GenScript Biotech Corp., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, New England Biolabs Inc., Novartis AG, OriGene Technologies Inc., PerkinElmer Inc., Synthego Corp., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this CRISPR Technology Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive CRISPR technology market growth during the next five years
  • Precise estimation of the CRISPR technology market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the CRISPR technology industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of CRISPR technology market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Application

    • 5.1 Market segments
      • Exhibit 24: Chart on Application - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
    • 5.2 Comparison by Application
      • Exhibit 26: Chart on Comparison by Application
      • Exhibit 27: Data Table on Comparison by Application
    • 5.3 Biological application - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Biological application - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Biological application - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Biological application - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Biological application - Year-over-year growth 2021-2026 (%)
    • 5.4 Agricultural application - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Agricultural application - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Agricultural application - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Agricultural application - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Agricultural application - Year-over-year growth 2021-2026 (%)
    • 5.5 Industrial application - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Industrial application - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Industrial application - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Industrial application - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Industrial application - Year-over-year growth 2021-2026 (%)
    • 5.6 Others - Market size and forecast 2021-2026
      • Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
      • Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
    • 5.7 Market opportunity by Application
      • Exhibit 44: Market opportunity by Application ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 46: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 48: Chart on Geographic comparison
      • Exhibit 49: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 UK - Market size and forecast 2021-2026
      • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.9 Canada - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.10 Germany - Market size and forecast 2021-2026
      • Exhibit 78: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.11 Japan - Market size and forecast 2021-2026
      • Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
      • Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 86: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 87: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 89: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 90: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 91: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 92: Matrix on vendor position and classification
            • 10.3 Danaher Corp.
              • Exhibit 93: Danaher Corp. - Overview
              • Exhibit 94: Danaher Corp. - Business segments
              • Exhibit 95: Danaher Corp. - Key news
              • Exhibit 96: Danaher Corp. - Key offerings
              • Exhibit 97: Danaher Corp. - Segment focus
            • 10.4 Editas Medicine Inc.
              • Exhibit 98: Editas Medicine Inc. - Overview
              • Exhibit 99: Editas Medicine Inc. - Product / Service
              • Exhibit 100: Editas Medicine Inc. - Key offerings
            • 10.5 GeneCopoeia Inc.
              • Exhibit 101: GeneCopoeia Inc. - Overview
              • Exhibit 102: GeneCopoeia Inc. - Product / Service
              • Exhibit 103: GeneCopoeia Inc. - Key offerings
            • 10.6 GenScript Biotech Corp.
              • Exhibit 104: GenScript Biotech Corp. - Overview
              • Exhibit 105: GenScript Biotech Corp. - Business segments
              • Exhibit 106: GenScript Biotech Corp. - Key news
              • Exhibit 107: GenScript Biotech Corp. - Key offerings
              • Exhibit 108: GenScript Biotech Corp. - Segment focus
            • 10.7 Intellia Therapeutics Inc.
              • Exhibit 109: Intellia Therapeutics Inc. - Overview
              • Exhibit 110: Intellia Therapeutics Inc. - Business segments
              • Exhibit 111: Intellia Therapeutics Inc. - Key offerings
              • Exhibit 112: Intellia Therapeutics Inc. - Segment focus
            • 10.8 Lonza Group Ltd.
              • Exhibit 113: Lonza Group Ltd. - Overview
              • Exhibit 114: Lonza Group Ltd. - Product / Service
              • Exhibit 115: Lonza Group Ltd. - Key news
              • Exhibit 116: Lonza Group Ltd. - Key offerings
            • 10.9 New England Biolabs Inc.
              • Exhibit 117: New England Biolabs Inc. - Overview
              • Exhibit 118: New England Biolabs Inc. - Product / Service
              • Exhibit 119: New England Biolabs Inc. - Key news
              • Exhibit 120: New England Biolabs Inc. - Key offerings
            • 10.10 OriGene Technologies Inc.
              • Exhibit 121: OriGene Technologies Inc. - Overview
              • Exhibit 122: OriGene Technologies Inc. - Product / Service
              • Exhibit 123: OriGene Technologies Inc. - Key offerings
            • 10.11 PerkinElmer Inc.
              • Exhibit 124: PerkinElmer Inc. - Overview
              • Exhibit 125: PerkinElmer Inc. - Business segments
              • Exhibit 126: PerkinElmer Inc. - Key news
              • Exhibit 127: PerkinElmer Inc. - Key offerings
              • Exhibit 128: PerkinElmer Inc. - Segment focus
            • 10.12 Thermo Fisher Scientific Inc.
              • Exhibit 129: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 130: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 131: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 132: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 133: Thermo Fisher Scientific Inc. - Segment focus

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 134: Inclusions checklist
                • Exhibit 135: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 136: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 137: Research methodology
                • Exhibit 138: Validation techniques employed for market sizing
                • Exhibit 139: Information sources
              • 11.5 List of abbreviations
                • Exhibit 140: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Crispr Technology Market market growth will increase by $2.88 bn during 2022-2026.
              The crispr technology market market is expected to grow at a CAGR of 19.34% during 2022-2026.
              Technavio has segmented the crispr technology market market by application (Biological application, Agricultural application, Industrial application, and Others) and geography (North America, Europe, Asia, and Rest of World (ROW)).
              Addgene Inc., Agilent Technologies Inc., Applied StemCell Inc., Caribou Biosciences Inc., Cellecta Inc., CRISPR Therapeutics AG, Danaher Corp., Editas Medicine Inc., GeneCopoeia Inc., GenScript Biotech Corp., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, New England Biolabs Inc., Novartis AG, OriGene Technologies Inc., PerkinElmer Inc., Synthego Corp., Thermo Fisher Scientific Inc. are a few of the key vendors in the crispr technology market market.
              North America will register the highest growth rate of 44% among the other regions. Therefore, the crispr technology market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the crispr technology market market growth are:
              • Increasing demand for treatment of genetic diseases
              • Advent of crispr/ Cas9
              The crispr technology market market vendors should focus on grabbing business opportunities from the biological application segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single User:

                Quick and easy buy and download option

              • Enterprise:

                Flexible option - Complimentary customization included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>